Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

NCT07501650 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Head and Neck Small Cell Carcinoma
Metastatic Head and Neck Cancer
Recurrent Head and Neck Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Definity
DEVICE: Ultrasound-Induced Microbubble Cavitation

Sponsor

Thomas Jefferson University

Collaborators

Lantheus Medical Imaging